Journal of General Internal Medicine

, Volume 23, Issue 12, pp 2095–2105

Clinical Decision Support Tools for Osteoporosis Disease Management: A Systematic Review of Randomized Controlled Trials

Original Article

Abstract

BACKGROUND

Studies indicate a gap between evidence and clinical practice in osteoporosis management. Tools that facilitate clinical decision making at the point of care are promising strategies for closing these practice gaps.

OBJECTIVE

To systematically review the literature to identify and describe the effectiveness of tools that support clinical decision making in osteoporosis disease management.

DATA SOURCES

Medline, EMBASE, CINAHL, and EBM Reviews (CDSR, DARE, CCTR, and ACP J Club), and contact with experts in the field.

REVIEW METHODS

Randomized controlled trials (RCTs) in any language from 1966 to July 2006 investigating disease management interventions in patients at risk for osteoporosis. Outcomes included fractures and bone mineral density (BMD) testing. Two investigators independently assessed articles for relevance and study quality, and extracted data using standardized forms.

RESULTS

Of 1,246 citations that were screened for relevance, 13 RCTs met the inclusion criteria. Reported study quality was generally poor. Meta-analysis was not done because of methodological and clinical heterogeneity; 77% of studies included a reminder or education as a component of their intervention. Three studies of reminders plus education targeted to physicians and patients showed increased BMD testing (RR range 1.43 to 8.67) and osteoporosis medication use (RR range 1.60 to 8.67). A physician reminder plus a patient risk assessment strategy found reduced fractures [RR 0.58, 95% confidence interval (CI) 0.37 to 0.90] and increased osteoporosis therapy (RR 2.44, CI 1.43 to 4.17).

CONCLUSION

Multi-component tools that are targeted to physicians and patients may be effective for supporting clinical decision making in osteoporosis disease management.

Key Words

osteoporosis disease management decision making randomized controlled trials 

Supplementary material

11606_2008_812_MOESM1_ESM.doc (138 kb)
Web Appendix(DOC 141 kb)

References

  1. 1.
    Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporosis Int. 1997;7:407–13.CrossRefGoogle Scholar
  2. 2.
    Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obst Gynecol. 2006;194:S3–11.CrossRefGoogle Scholar
  3. 3.
    National Osteoporosis Society. Available at: http://www.nos.org.uk/: Accessed September, 2008.
  4. 4.
    Osteoporosis Canada. Available at: http://www.osteoporosis.ca/english/home/: Accessed September, 2008.
  5. 5.
    Hajcsar EE, Hawker G, Bogoch ER. Investigation and treatment of ostoporosis in patients with fragility fractures. CMAJ. 2000;163:819–22.PubMedGoogle Scholar
  6. 6.
    Johnell O, Kanis JA, Oden A, et al. Mortality after osteoporotic fractures. Osteoporosis Int. 2004;15:38–42.CrossRefGoogle Scholar
  7. 7.
    Reginster J, Burlet N. Osteoporosis: A still increasing prevalence. Bone. 2006;38:S4–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Lips P, van Schoor NM. Quality of life in patients with osteoporosis. Osteoporosis Int. 2005;16:447–55.CrossRefGoogle Scholar
  9. 9.
    Goeree ROB, Pettitt DB, Cuddy L, et al. An assessment of the burden of illness due to osteoporosis in Canada. J Soc Obstet Gynaecol Can. 1996;18(Suppl):15–24.Google Scholar
  10. 10.
    Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. The Lancet. 2002;359:1761–7.CrossRefGoogle Scholar
  11. 11.
    Poole KES, Compston JE. Clinical review: Osteoporosis and its management. BMJ. 2006;333:1251–6.PubMedCrossRefGoogle Scholar
  12. 12.
    International Osteoporosis Foundation. Available at: http://www.iofbonehealth.org/facts-and-statistics.html: Accessed September 2008.
  13. 13.
    Brown JP, Josse RG, for the Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada (revised, August 26, 2004). CMAJ. 2002;167(10):S1–34.PubMedGoogle Scholar
  14. 14.
    Osteoporosis, Clinical Guidelines for Prevention and Treatment: Update on pharmacological interventions and algorithm for management. Royal College of Physicians, Bone and Tooth Society of Great Britain, 2003. Available at: http://www.rcplondon.ac.uk: Accessed September 2008.
  15. 15.
    ACOG Committee on Practice Bulletins. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 50, January 2004. Osteoporosis Obstet Gynecol. 2004;103(1):203–16.Google Scholar
  16. 16.
    Jaglal SB, McIsaac WJ, Hawker G, et al. Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process. Osteoporosis Int. 2003;14:672–6.CrossRefGoogle Scholar
  17. 17.
    Jaglal SB, Carroll J, Hawker G, et al. How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Phys. 2003;49:462–8.Google Scholar
  18. 18.
    Papaioannou A, Giangregorio L, Kvern B, Boulos P, Ioannidis G, Adachi JD. The osteoporosis care gap in Canada. BMC Musculoskelet Disord. 2004;6:5–11.Google Scholar
  19. 19.
    Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assessment. 2004;(86):iii–iv, 1–72.Google Scholar
  20. 20.
    Smith SA, Murphy ME, Huschka TR, et al. Impact of a diabetes electronic management system on the care of patients seen in a subspecialty diabetes clinic. Diabetes Care. 1998;21:972–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Baker AM, Lafatat JE, Ward RE, Whitehouse F, Divine G. A web-based diabetes care management support system. J Qual Improv. 2001;27(4):179–90.Google Scholar
  22. 22.
    Finkelstein J, O’connor G, Friedmann RH. Development and implementation of the home asthma telemonitoring (HAT) system to facilitate asthma self-care. Medinfo. 2001;10(Pt 1):810–4.Google Scholar
  23. 23.
    Roccaforte R, Demers C, Baldassarre F, Teo KK, Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail. 2005;7(7):1133–44.PubMedCrossRefGoogle Scholar
  24. 24.
    Gonseth J, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J. 2004;25:1570–95.PubMedCrossRefGoogle Scholar
  25. 25.
    Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ. 2000;162(9):1289–94.PubMedGoogle Scholar
  26. 26.
    Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR, Hedges Team. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ. 2005;330(7501):1179.PubMedCrossRefGoogle Scholar
  27. 27.
    Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282(11):1054–60.PubMedCrossRefGoogle Scholar
  28. 28.
    Moyer A, Finney JW. Rating methodologic quality: toward improved assessment and investigation. Account Res. 2005;12(4):299–313.PubMedGoogle Scholar
  29. 29.
    Egger M, Smith GD, Altman DG. Systematic reviews in health care: Meta-analysis in context. London: BMJ Publishing Group; 2001:309–10;395–6.Google Scholar
  30. 30.
    Barr RJ, Stewart A, Torgerson DJ, Seymour DG, Reid DM. Screening elderly women for risk of future fractures—Participation rates and impact on incidence of falls and fractures. Calcif Tissue Int. 2005;76:243–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Bliuc D, Eisman JA, Center JR. A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures. Osteoporos Int. 2006;17(9):1309–17.PubMedCrossRefGoogle Scholar
  32. 32.
    Boyd JL, Holcomb JP, Rothenberg RJ. Physician treatment of osteoporosis in response to heel ultrasound bone mineral density reports. J Clin Densitometry. 2002;5(4):375–81.CrossRefGoogle Scholar
  33. 33.
    Devereux K, Robertson D, Briffa NK. Effects of a water-based program on women 65 years and over: a randomized controlled trial. Aust J of Physiother. 2005;51:102–8.Google Scholar
  34. 34.
    Feldstein A, Elmer PJ, Smith DH, et al. Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trail. J Am Geriatr Soc. 2006;54(3):450–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Gardner MJ, Brophy RH, Demetrakopoulos D, et al. Interventions to improve osteoporosis treatment following hip fracture. J Bone and Joint Surg. 2005;87:3–7.CrossRefGoogle Scholar
  36. 36.
    LaCroix AZ, Buist DSM, Brenneman SK, Abbott TA. Evaluation of three population-based strategies for fracture prevention. Medical Care. 2005;43:293–302.PubMedCrossRefGoogle Scholar
  37. 37.
    McDonough RP, Doucette WR, Kumbera P, Klepser DG. An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value in Health. 2005;8(1):24–31.PubMedCrossRefGoogle Scholar
  38. 38.
    Morrison LS, Tobias JH. Effect of a case-finding strategy for osteoporosis on bisphosphonate prescribing in primary care. Osteoporosis Int. 2005;16(1):71–7.CrossRefGoogle Scholar
  39. 39.
    Rolnick SJ, Kopher R. What is the impact of osteoporosis education and bone mineral density testing for postmenopausal women in a managed care setting? Menopause. 2001;8(2):141–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Solomon DH, Katz JN, La Tourette AM, Coblyn JS. Multifaceted intervention to improve reumatologists’ management of glucocorticoid-induced osteoporosis: A randomized controlled trial. Arthritis & Rheumatism. 2004;51:383–7.CrossRefGoogle Scholar
  41. 41.
    Solomon DH, Finkelsteing JS, Polinski JM, et al. A randomized controlled trial of mailed osteoporosis education to older adults. Osteoporosis Int. 2006;17:760–7.CrossRefGoogle Scholar
  42. 42.
    Solomon DH, Polinski JM, Stedman M, et al. Improving care of patients at-risk for osteoporosis: A randomized controlled trial. J Gen Intern Med. 2007;22(3):362–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Allen ML, Wyatt LE. Guidelines for the diagnosis, screening, and treatment of osteoporosis in women. Adv Studies Med. 2005;5(10):518–23.Google Scholar
  44. 44.
    Ashworth NL, Chad KE, Harrison EL, Reeder BA, Marshall SC. Home versus center based physical activity programs in older adults. Cochrane Database Syst Rev. 2005;25(1):CD004017, Jan.Google Scholar
  45. 45.
    Bai B, Wang KZ, Liu WK, Song JH, Chen JC. Comprehensive treatment for old patients with hip fractures. Chin J Traumatol. 2003;6(5):297–301.PubMedGoogle Scholar
  46. 46.
    Berard A, Bravo G, Gauthier P. Meta-analysis of the effectiveness of physical activity for the prevention of bone loss in postmenopausal women. Osteoporosis Int. 1997;7(4):331–7.CrossRefGoogle Scholar
  47. 47.
    Berarducci A. The effects of an osteoporosis preventive cognitive/behavioural intervention on knowledge, self-efficacy, role strain, and intention in midlife women. University of South Florida PhD dissertation.Google Scholar
  48. 48.
    Blalock SJ, Currey SS, DeVellis RF, et al. Effects of educational materials concerning osteoporosis on women’s knowledge, beliefs, and behaviour. Am J Health Prom. 2000;14(3):161–9.Google Scholar
  49. 49.
    Bonaiuti D, Cranney A, Iovine R, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. 2002;(3):CD000333.Google Scholar
  50. 50.
    Boulos P, Adachi JD. Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis. Clin Exp Rheumatol. 2000;18(Suppl 21):S79–86.Google Scholar
  51. 51.
    Brenneman SK, Lacroix AZ, Buist DSM, Chen Y, Abbott TA III. Evaluation of decision rules to identify postmenopausal women for inervention related to osteoporosis. Dis Manage. 2003;6:159–68.CrossRefGoogle Scholar
  52. 52.
    Buist DSM, LaCroix AZ, Manfredonia D, Abbott T. Identifying postmenopausal women at high risk of fracture in populations: a comparison of three strategies. J Am Geriatrics Soc. 2002;50(6):1031–8.CrossRefGoogle Scholar
  53. 53.
    Colon-Emeric CS, Caminis J, Suh TT, et al. The HORIZON Recruitment Fracture Trial: Design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair. Curr Med Res Opin. 2004;20(6):903–10.PubMedCrossRefGoogle Scholar
  54. 54.
    Delafuente JC, Weakley DF. Can an educational program for residents of assisted living facilities improve drug utilization for osteoporosis? Consultant Pharmacist. 2005;20(2):137–40.PubMedGoogle Scholar
  55. 55.
    Devogelaer J-P, Goemaere S, Boonen S, et al. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: A consensus document of the Belgian Bone Club. Osteoporosis Int. 2006;17(1):8–19.CrossRefGoogle Scholar
  56. 56.
    Dhillon V, Creiger J, Hannan J, Hurst N, Nuki G. The effect of DXA scanning on clinical decision making by general practitioners: A randomized, prospective trial of direct access versus referral to a hospital consultant. Osteoporosis Int. 2003;14:326–33.CrossRefGoogle Scholar
  57. 57.
    Edwards BJ, Brooks ER, Langman CB. Osteoporosis screening of postmenopausal women in the primary care setting: A case-based approach. Gender Med. 2004;1(2):70–85.CrossRefGoogle Scholar
  58. 58.
    Gold DT, Shipp KM, Pieper CF, Duncan PW, Martinez S, Lyles KW. Group treatment improves trunk strength and psychological status in older women with vertebral fractures: results osf a randomized, clinical trial. J Am Geriatr Soc. 2004;52:1471–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Hunskaar S, Hannestad YS, Backe B, Matheson I. Direct, mailing of consensus recommendations did not alter GPs’ knowledge and prescription of oestrogen in the menopause. Scand J Prim Health Care. 1996;14(4):203–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Josse R, Tenengouse AM, Hanley DA, et al. Clinical practice guidelines for the diagnosis and management of osteoporosis. CMAJ. 1996;155(8):1113–29.Google Scholar
  61. 61.
    Lock CA, Lecouturier J, Mason JM, Dickinson HO. Lifestyle interventions to prevent osteoporotic fractures: A systematic review. Osteoporosis Int. 2006;17(1):20–8.CrossRefGoogle Scholar
  62. 62.
    McGinley AM. Effect of Web-based computer-tailoring on women’s intention to continue or begin to use hormone replacement therapy to lower their risk for osteoporosis. University of Pennsylvania PhD Dissertation 2002.Google Scholar
  63. 63.
    Nelson ME, Fiatarone MA, Morganit CM, Trice I, Greenberg RA, Evans WJ. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures: a randomized controlled trial. JAMA. 1994;272:1909–14.PubMedCrossRefGoogle Scholar
  64. 64.
    O’Connor AM, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003;(2):CD001431.Google Scholar
  65. 65.
    Polinski JM, Brookhart MA, Katz JN, et al. Educational outreach (academic detailing) regarding osteoporosis in primary care. Pharmacoepidemiol Drug Safety. 2005;14:843–50.CrossRefGoogle Scholar
  66. 66.
    Feder G, Cryer D, Donovan S, Carter Y. Guidelines for the prevention of falls in people over 65. BMJ. 2000;321:1007–11.PubMedCrossRefGoogle Scholar
  67. 67.
    Rothert ML, Holmes-Rovner M, Rovner D, et al. An educational intervention as decision support for menopausal women. Res Nurs Health. 1997;20(5):377–87.PubMedCrossRefGoogle Scholar
  68. 68.
    Silverman SL, Greenwald M, Klein RA, Drinkwater BL. Effect of bone density information on decisions about hormone replacement therapy: a randomized trail. Obstetrics Gynecol. 1997;89(3):321–5.CrossRefGoogle Scholar
  69. 69.
    Stock JL, Waud CE, Coderre JA, et al. Clinical reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis. A randomized trial. Ann Intern Med. 1998;128(12 Pt 1):996–9.PubMedGoogle Scholar
  70. 70.
    Winzenberg T, Oldenburg B, Frendin S, De Wit L, Riley M, Jones G. The effect on behaviour and bone mineral density of individualized bone mineral density feedback and educational interventions in premenopausal women: a randomized controlled trial. BMC Pub Health. 2006;6:12.CrossRefGoogle Scholar
  71. 71.
    Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam consultation on meta-analysis. J Clin Epidemiol. 1995;48:167–71.PubMedCrossRefGoogle Scholar
  72. 72.
    Sullivan F, Wyatt JC. How decision support tools help define clinical problems. BMJ. 2005;331:831–3.PubMedCrossRefGoogle Scholar
  73. 73.
    Randolph AG, Haynes RB, Wyatt JC, Cook DJ, Guyatt GH. Users’ guides to the medical literature XVII. How to use an article evaluating the clinical impact of a computer-based clinical decision support system. JAMA. 1999;281:67–74.CrossRefGoogle Scholar
  74. 74.
    Garg AX, Adhikari NKJ, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293:1223–38.PubMedCrossRefGoogle Scholar
  75. 75.
    Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330:765–73.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2008

Authors and Affiliations

  1. 1.Department of Health Policy, Management and Evaluation, Faculty of MedicineUniversity of TorontoTorontoCanada
  2. 2.Department of MedicineUniversity of CalgaryCalgaryCanada

Personalised recommendations